Search results
Analyst Report: Pfizer Inc.
Morningstar Research via Yahoo Finance· 2 days agoWhile it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal ...
Why I'm Buying This Beaten-Down, High-Yield Dividend Stock Hand Over Fist
Motley Fool via Yahoo Finance· 4 days agoThe drugmaker has faced some big challenges and has more on the way. Pfizer's revenue in 2023 fell...
Pfizer profits drop on lower Covid-19 product sales
Digital Journal· 3 days agoPfizer reported a drop in profits on lower sales of Covid-19 related profits Wednesday as it steers investments to other pharmaceutical areas and...
Pfizer beats revenue estimates, raises profit outlook on cost cuts and strong non-Covid sales
NBC Los Angeles· 3 days agoPfizer reported first-quarter revenue that beat expectations and hiked its full-year profit outlook,...
Pfizer Shares Jump After Beating Estimates
The Wall Street Journal· 3 days agoPfizer Chief Executive Albert Bourla said in an interview Wednesday he was encouraged but that the company's stock is undervalued.
Two possible bird flu vaccines could be available within weeks, if needed
NBC News via Yahoo News· 3 days agoThe U.S. has two vaccines ready that could begin shipping widely within a few weeks if the H5N1 bird...
GSK raises forecasts on strong vaccine, HIV drug sales
BioPharma Dive via Yahoo Finance· 3 days agoSales of the shingles vaccine Shingrix and the RSV shot Arexvy helped fuel quarterly revenue totals...
The true tragedy of the Covid-19 vaccines
Daily Telegraph· 3 days agoIndeed, some public health officials exaggerated the benefits and underplayed some of the risks. Thrombosis caused by the AstraZeneca vaccine and...
Moderna expects CDC to view its RSV vaccine as equal to rival shots
Reuters· 2 days ago, opens new tab said on Thursday it expects U.S. Center for Disease Control and Prevention (CDC)...
The Motley Fool: Pfizer offers a pfat 6.4% dividend
Dallas Morning News· 6 days agoShares of Pfizer were recently down more than 35% over the past year — in part because the market’s enthusiasm for its COVID-19 vaccine Comirnaty and...
